Product NDC: | 68782-001 |
Proprietary Name: | Macugen |
Non Proprietary Name: | pegaptanib sodium |
Active Ingredient(s): | 3.47 mg/mL & nbsp; pegaptanib sodium |
Administration Route(s): | INTRAVITREAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68782-001 |
Labeler Name: | Eyetech Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021756 |
Marketing Category: | NDA |
Start Marketing Date: | 20041217 |
Package NDC: | 68782-001-02 |
Package Description: | 1 SYRINGE in 1 CARTON (68782-001-02) > .09 mL in 1 SYRINGE |
NDC Code | 68782-001-02 |
Proprietary Name | Macugen |
Package Description | 1 SYRINGE in 1 CARTON (68782-001-02) > .09 mL in 1 SYRINGE |
Product NDC | 68782-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pegaptanib sodium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVITREAL |
Start Marketing Date | 20041217 |
Marketing Category Name | NDA |
Labeler Name | Eyetech Inc. |
Substance Name | PEGAPTANIB SODIUM |
Strength Number | 3.47 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Oligonucleotides [Chemical/Ingredient],Aptamers, Nucleotide [Chemical/Ingredient] |